Stockreport

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 [Yahoo! Finance]

bioAffinity Technologies, Inc.  (BIAF) 
PDF Number of physician offices signed increased 75% over Q2 2024 Reaffirmed $9.6 million 2024 revenue forecast for wholly owned Precision Pathology subsidiary SAN ANTO [Read more]